Article info

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Free

Authors

  1. Correspondence to Atsushi Sakuraba, Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA; asakurab{at}medicine.bsd.uchicago.edu
View Full Text

Citation

Akiyama S, Hamdeh S, Micic D, et al
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis

Publication history

  • Received August 21, 2020
  • Revised September 30, 2020
  • Accepted September 30, 2020
  • First published October 13, 2020.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.